These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29991097)

  • 1. Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure.
    Elgouhari H; Ahmed K; Niazi M; Huntington MK
    S D Med; 2018 Mar; 71(3):112-115. PubMed ID: 29991097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure.
    Oye M; Sanders K; Ghali M; Alkhasawneh A
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32601138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hypertension and intrahepatic cholestasis in hepatic amyloidosis.
    Zeijen RN; Sels JP; Flendrig JA; Arends JW
    Neth J Med; 1991 Jun; 38(5-6):257-61. PubMed ID: 1922599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure.
    Ales NC; Daniels JT; Frizell ER; Koff JM; Kaplan KJ; Wortmann GW
    South Med J; 2001 Oct; 94(10):1036-8. PubMed ID: 11702819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL).
    Yamamoto T; Maeda N; Kawasaki H
    J Gastroenterol; 1995 Jun; 30(3):393-7. PubMed ID: 7647907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrahepatic cholestasis and hepatic failure due to hepatic amyloidosis].
    de Rivas Otero B; Gil Martínez P
    Med Clin (Barc); 2002 Nov; 119(17):678. PubMed ID: 12453382
    [No Abstract]   [Full Text] [Related]  

  • 8. Portal hypertension and intrahepatic cholestasis in primary amyloidosis.
    Çağlar E; Özbay G; Kalyon H; Sonsuz A
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():258-9. PubMed ID: 25910329
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe Obstructive Cholestasis and Hypercalcemia Caused by Light-Chain Amyloidosis: A Case Report.
    Davoudi Z; Bidari F; Jamali E; Nikpour S
    Iran J Med Sci; 2022 Jan; 47(1):73-77. PubMed ID: 35017780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic amyloidosis presenting as severe intrahepatic cholestasis: a case report and review of the literature.
    Hoffman MS; Stein BE; Davidian MM; Rosenthal WS
    Am J Gastroenterol; 1988 Jul; 83(7):783-5. PubMed ID: 3289380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome.
    Michopoulos S; Petraki K; Petraki C; Dimopoulos MA
    Dig Dis Sci; 2002 Apr; 47(4):730-4. PubMed ID: 11991600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis.
    Norero B; Pérez-Ayuso RM; Duarte I; Ramirez P; Soza A; Arrese M; Benítez C
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):142-9. PubMed ID: 24378278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe intrahepatic cholestasis as the initial manifestation of light chain amyloidosis.
    Martínez-Acitores de la Mata D; Bravo Meléndez S; Ceballos Bolaños C; Villegas IA; Mateos Rodriguez MC; Huarte Muniesa MP; Oquiñena Legaz S; Alvarellos Outerio M; Pérez Ricarte S
    Gastroenterol Hepatol; 2021 Jan; 44(1):29-31. PubMed ID: 32736885
    [No Abstract]   [Full Text] [Related]  

  • 14. Myeloma associated amyloidosis presenting as subacute liver failure.
    Cross TJ; Wendon JA; Quaglia A; Salisbury JR; Heneghan MA; Harrison PM
    Postgrad Med J; 2006 Jul; 82(969):e13. PubMed ID: 16822912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver.
    Melkebeke P; Vandepitte J; Hannon R; Fevery J
    Digestion; 1980; 20(5):351-7. PubMed ID: 7390060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
    Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
    Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestasis and renal failure in a patient with secondary amyloidosis.
    Unsal C; Paydaş S; Gönlüşen G
    Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver failure caused by light chain deposition disease associated with multiple myeloma.
    Mena-Durán A; Muñoz Vicente E; Pareja Llorens G; Sanchis Cervera J
    Intern Med; 2012; 51(7):773-6. PubMed ID: 22466837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma].
    Tabata S; Kurata M; Takeda J; Funayama Y; Yamauchi N; Aoki K; Kato A; Ono Y; Arima H; Takiuchi Y; Nagano S; Matsushita A; Imai Y; Ishikawa T; Takahashi T
    Rinsho Ketsueki; 2012 Nov; 53(11):1906-10. PubMed ID: 23257671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
    Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
    J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.